Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
12 | 124879441 | intron variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
12 | 124879441 | intron variant | C/A;T | snv |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
12 | 124869264 | intron variant | T/A | snv | 0.11 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
12 | 124869264 | intron variant | T/A | snv | 0.11 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
0.882 | 0.040 | 12 | 124863717 | missense variant | C/T | snv | 0.10 | 8.6E-02 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.882 | 0.040 | 12 | 124863717 | missense variant | C/T | snv | 0.10 | 8.6E-02 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.882 | 0.040 | 12 | 124863717 | missense variant | C/T | snv | 0.10 | 8.6E-02 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
1.000 | 0.040 | 12 | 124855901 | intron variant | G/A | snv | 0.47 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
12 | 124853983 | intron variant | C/T | snv | 0.63 |
|
0.800 | 1.000 | 3 | 2012 | 2019 | ||||||||||
|
12 | 124853983 | intron variant | C/T | snv | 0.63 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.080 | 12 | 124853790 | intron variant | T/C | snv | 8.2E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.080 | 12 | 124853790 | intron variant | T/C | snv | 8.2E-02 |
|
Nervous System Diseases; Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.160 | 12 | 124851404 | intron variant | C/A | snv | 6.5E-02 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.160 | 12 | 124851404 | intron variant | C/A | snv | 6.5E-02 |
|
Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Male Urogenital Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
12 | 124841232 | intron variant | C/T | snv | 2.2E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.040 | 12 | 124840252 | intron variant | C/A | snv | 8.7E-02 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.120 | 12 | 124836304 | intron variant | C/T | snv | 0.38 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.810 | 1.000 | 3 | 2011 | 2017 | |||||||
|
0.925 | 0.120 | 12 | 124836304 | intron variant | C/T | snv | 0.38 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 12 | 124833036 | intron variant | C/T | snv | 0.49 |
|
Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 12 | 124832197 | intron variant | C/T | snv | 0.18 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.040 | 12 | 124831509 | intron variant | A/C | snv | 0.16 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
12 | 124831101 | intron variant | A/G | snv | 0.26 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
12 | 124831101 | intron variant | A/G | snv | 0.26 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
0.763 | 0.160 | 12 | 124827879 | intron variant | G/C | snv | 0.32 |
|
Cardiovascular Diseases | 0.040 | 0.750 | 4 | 2010 | 2018 | |||||||
|
0.763 | 0.160 | 12 | 124827879 | intron variant | G/C | snv | 0.32 |
|
Cardiovascular Diseases | 0.040 | 0.750 | 4 | 2010 | 2018 |